NM_006612.6:c.1165+4G>A

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BS1BS2

The NM_006612.6(KIF1C):​c.1165+4G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00545 in 1,614,186 control chromosomes in the GnomAD database, including 29 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0043 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0056 ( 27 hom. )

Consequence

KIF1C
NM_006612.6 splice_region, intron

Scores

2
Splicing: ADA: 0.0001659
1

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:3

Conservation

PhyloP100: 0.226

Publications

0 publications found
Variant links:
Genes affected
KIF1C (HGNC:6317): (kinesin family member 1C) The protein encoded by this gene is a member of the kinesin-like protein family. The family members are microtubule-dependent molecular motors that transport organelles within cells and move chromosomes during cell division. Mutations in this gene are a cause of spastic ataxia 2, autosomal recessive. [provided by RefSeq, May 2014]
KIF1C Gene-Disease associations (from GenCC):
  • spastic ataxia 2
    Inheritance: AR, AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP6
Variant 17-5005004-G-A is Benign according to our data. Variant chr17-5005004-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 445377.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00432 (658/152350) while in subpopulation NFE AF = 0.00679 (462/68026). AF 95% confidence interval is 0.00628. There are 2 homozygotes in GnomAd4. There are 318 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KIF1CNM_006612.6 linkc.1165+4G>A splice_region_variant, intron_variant Intron 13 of 22 ENST00000320785.10 NP_006603.2
KIF1CXM_005256424.3 linkc.1165+4G>A splice_region_variant, intron_variant Intron 14 of 23 XP_005256481.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KIF1CENST00000320785.10 linkc.1165+4G>A splice_region_variant, intron_variant Intron 13 of 22 1 NM_006612.6 ENSP00000320821.5

Frequencies

GnomAD3 genomes
AF:
0.00433
AC:
659
AN:
152232
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00104
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00164
Gnomad ASJ
AF:
0.00922
Gnomad EAS
AF:
0.000577
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00743
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00681
Gnomad OTH
AF:
0.00573
GnomAD2 exomes
AF:
0.00467
AC:
1172
AN:
251166
AF XY:
0.00470
show subpopulations
Gnomad AFR exome
AF:
0.000738
Gnomad AMR exome
AF:
0.00165
Gnomad ASJ exome
AF:
0.00904
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00758
Gnomad NFE exome
AF:
0.00711
Gnomad OTH exome
AF:
0.00457
GnomAD4 exome
AF:
0.00556
AC:
8134
AN:
1461836
Hom.:
27
Cov.:
32
AF XY:
0.00547
AC XY:
3976
AN XY:
727218
show subpopulations
African (AFR)
AF:
0.000657
AC:
22
AN:
33480
American (AMR)
AF:
0.00174
AC:
78
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00972
AC:
254
AN:
26136
East Asian (EAS)
AF:
0.000126
AC:
5
AN:
39700
South Asian (SAS)
AF:
0.000325
AC:
28
AN:
86258
European-Finnish (FIN)
AF:
0.00822
AC:
439
AN:
53388
Middle Eastern (MID)
AF:
0.000867
AC:
5
AN:
5768
European-Non Finnish (NFE)
AF:
0.00629
AC:
6998
AN:
1111990
Other (OTH)
AF:
0.00505
AC:
305
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
467
934
1402
1869
2336
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
242
484
726
968
1210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00432
AC:
658
AN:
152350
Hom.:
2
Cov.:
32
AF XY:
0.00427
AC XY:
318
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.00103
AC:
43
AN:
41582
American (AMR)
AF:
0.00163
AC:
25
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00922
AC:
32
AN:
3470
East Asian (EAS)
AF:
0.000578
AC:
3
AN:
5186
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00743
AC:
79
AN:
10628
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00679
AC:
462
AN:
68026
Other (OTH)
AF:
0.00567
AC:
12
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
36
72
107
143
179
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00597
Hom.:
2
Bravo
AF:
0.00357
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00562
EpiControl
AF:
0.00664

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

KIF1C: BS2 -

Sep 05, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 31, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary spastic paraplegia Uncertain:1
Sep 04, 2020
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Spastic ataxia 2 Benign:1
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
20
DANN
Benign
0.44
PhyloP100
0.23
Mutation Taster
=25/75
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00017
SpliceAI score (max)
0.30
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.30
Position offset: 2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs192489748; hg19: chr17-4908299; API